Search Results - "Njølstad, I."

C‐reactive protein, obesity, and the risk of arterial and venous thrombosis by Horvei, L. D., Grimnes, G., Hindberg, K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Brox, J., Brækkan, S. K., Hansen, J.‐B.

“…Essentials We performed repeated measurements of C‐reactive protein (CRP) and obesity in a cohort study. CRP was associated with risk of myocardial infarction…”
Get full text

Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study by Enga, K. F., Rye‐Holmboe, I., Hald, E. M., Løchen, M.‐L., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Braekkan, S. K., Hansen, J.‐B.

“…Summary Aims Whether atrial fibrillation is related to risk of venous thromboembolism (VTE) has not been extensively studied. Therefore, we investigated the…”
Get full text

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study by Rinde, L. B., Lind, C., Småbrekke, B., Njølstad, I., Mathiesen, E. B., Wilsgaard, T., Løchen, M.‐L., Hald, E. M., Vik, A., Brækkan, S. K., Hansen, J.‐B.

“…Essentials Registry‐based studies indicate a link between arterial‐ and venous thromboembolism (VTE). We studied this association in a cohort with confounder…”
Get full text

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease by Bønaa, Kaare H, Mannsverk, Jan, Wiseth, Rune, Aaberge, Lars, Myreng, Yngvar, Nygård, Ottar, Nilsen, Dennis W, Kløw, Nils-Einar, Uchto, Michael, Trovik, Thor, Bendz, Bjørn, Stavnes, Sindre, Bjørnerheim, Reidar, Larsen, Alf-Inge, Slette, Morten, Steigen, Terje, Jakobsen, Ole J, Bleie, Øyvind, Fossum, Eigil, Hanssen, Tove A, Dahl-Eriksen, Øystein, Njølstad, Inger, Rasmussen, Knut, Wilsgaard, Tom, Nordrehaug, Jan E

“…In a trial involving over 9000 patients with coronary artery disease who were assigned to receive either contemporary drug-eluting stents or bare-metal stents,…”
Get full text

Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up by Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., Jorde, R.

“…Diabet. Med. 27, 1107–1115 (2010) Aims  We wanted to test the hypothesis that low serum 25‐hydroxyvitamin D (25(OH)D) concentrations are associated with…”
Get full text

Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984―2007 by SANDVEI, M. S, MATHIESEN, E. B, ROMUNDSTAD, P. R, VATTEN, L. J, MIILLER, T. B, LINDEKLEIV, H, INGEBRIGTSEN, T, NJØLSTAD, I, WILSGAARD, T, LØCHEN, M.-L, VIK, A

“…The incidence of aneurysmal subarachnoid hemorrhage (aSAH) ranges from 4 to 10 per 100,000 person-years in most countries, and 30-day case fatality is high…”
Get full text

Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study by Småbrekke, B., Rinde, L. B., Hald, E. M., Njølstad, I., Mathiesen, E. B., Johnsen, S. H., Hansen, J.‐B., Brækkan, S. K., Lijfering, W. M.

“…Summary Essentials The relationship between atherosclerosis and venous thromboembolism (VTE) is controversial. In total, 10 426 participants recruited from the…”
Get full text

Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study by BRÆKKAN, S. K., MATHIESEN, E. B., NJØLSTAD, I., WILSGAARD, T., STØRMER, J., HANSEN, J. B.

“…Background: Recent studies indicate that arterial cardiovascular diseases and venous thromboembolism (VTE) share common risk factors. A family history of…”
Get full text

Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study by VIK, A., MATHIESEN, E. B., BROX, J., WILSGAARD, T., NJØLSTAD, I., JØRGENSEN, L., HANSEN, J.‐B.

“…Background: Osteoprotegerin (OPG) concentration in serum is associated with the presence and severity of atherosclerosis. Objective: To investigate the…”
Get full text

Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study by Lerstad, G., Brodin, E. E., Enga, K. F., Jorde, R., Schirmer, H., Njølstad, I., Svartberg, J., Brækkan, S. K., Hansen, J.‐B.

“…Summary Background HbA1c, a marker of average plasma glucose level during the previous 8–12 weeks, is associated with the future risk of cardiovascular disease…”
Get full text

Atrial fibrillation is associated with cognitive decline in stroke‐free subjects: the Tromsø Study by Tiwari, S., Løchen, M. L., Jacobsen, B. K., Hopstock, L. A., Nyrnes, A., Njølstad, I., Mathiesen, E. B., Arntzen, K. A., Ball, J., Stewart, S., Wilsgaard, T., Schirmer, H.

“…Background and purpose Previous studies have shown associations between atrial fibrillation (AF) and cognitive decline. We investigated this association in a…”
Get full text

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study by Vikan, T, Johnsen, S. H, Schirmer, H, Njølstad, I, Svartberg, J

“…The role of testosterone in the development of cardiovascular disease is controversial. Recent observational studies, however, suggest a protective role of…”
Get full text

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project by Conroy, R.M., Pyörälä, K., Fitzgerald, A.P., Sans, S., Menotti, A., De Backer, G., De Bacquer, D., Ducimetière, P., Jousilahti, P., Keil, U., Njølstad, I., Oganov, R.G., Thomsen, T., Tunstall-Pedoe, H., Tverdal, A., Wedel, H., Whincup, P., Wilhelmsen, L., Graham, I.M.

“…Aims The SCORE project was initiated to develop a risk scoring system for use in the clinical management of cardiovascular risk in European clinical practice…”
Get full text

Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study by BORCH, K. H., BRÆKKAN, S. K., MATHIESEN, E. B., NJØLSTAD, I., WILSGAARD, T., STØRMER, J., HANSEN, J.‐B.

“…Background: The metabolic syndrome is a cluster of cardiovascular risk factors, including abdominal obesity, hypertension, dyslipidemia and insulin resistance,…”
Get full text

Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: A cohort study by LINDEKLEIV, H, SANDVEI, M. S, NJØLSTAD, I, LØCHEN, M.-L, ROMUNDSTAD, P. R, VATTEN, L, INGEBRIGTSEN, T, VIK, A, MATHIESEN, E. B

“…The purpose of this study was to investigate sex differences in the major established risk factors for aneurysmal subarachnoid hemorrhage (aSAH) in a large,…”
Get full text

Combined analyses and extended follow‐up of two randomized controlled homocysteine‐lowering B‐vitamin trials by Ebbing, M., Bønaa, K. H., Arnesen, E., Ueland, P. M., Nordrehaug, J. E., Rasmussen, K., Njølstad, I., Nilsen, D. W., Refsum, H., Tverdal, A., Vollset, S. E., Schirmer, H., Bleie, Ø., Steigen, T., Midttun, Ø., Fredriksen, Å., Pedersen, E. R., Nygård, O.

“…  Ebbing M., Bønaa K.H., Arnesen E., Ueland P.M., Nordrehaug J.E., Rasmussen K., Njølstad I., Nilsen D.W., Refsum H., Tverdal A., Vollset S.E., Schirmer H.,…”
Get full text

Relation between serum osteoprotegerin and carotid intima media thickness in a general population – the Tromsø Study by VIK, A., MATHIESEN, E. B., BROX, J., WILSGAARD, T., NJØLSTAD, I., JØRGENSEN, L., HANSEN, J.‐B.

“…Background: Previous studies have reported conflicting results on the relation between serum osteoprotegerin (OPG) concentration and carotid intima media…”
Get full text

Risk factors for aneurysmal subarachnoid hemorrhage - BMI and serum lipids: 11-year follow-up of the HUNT and the Tromsø Study in Norway by Sandvei, M. S., Lindekleiv, H., Romundstad, P. R., Müller, T. B., Vatten, L. J., Ingebrigtsen, T., Njølstad, I., Mathiesen, E. B., Vik, A.

“…Sandvei MS, Lindekleiv H, Romundstad PR, Müller TB, Vatten LJ, Ingebrigtsen T, Njølstad I, Mathiesen EB, Vik A. Risk factors for aneurysmal subarachnoid…”
Get full text

Single‐nucleotide polymorphism, rs1799941 in the Sex Hormone‐Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study by Svartberg, J., Schirmer, H., Wilsgaard, T., Mathiesen, E. B., Njølstad, I., Løchen, M.‐L., Jorde, R.

“…Summary Low testosterone levels are associated with metabolic and cardiovascular disease risk factor, and have been shown to predict type 2 diabetes mellitus…”
Get full text

Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population – the Tromsø study by VIK, A., MATHIESEN, E. B., JOHNSEN, S. H., BROX, J., WILSGAARD, T., NJØLSTAD, I., HANSEN, J.‐B.

“…Background: Intervention studies in animal models suggest that osteoprotegerin (OPG) functions as an inhibitor or marker of atherosclerosis, whereas one…”
Get full text